R.M. Sincerbeaux Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.9M | Hold |
55,400
| – | – | 7.41% | 4 |
|
|
2026
Q1 | $12M | Hold |
55,400
| – | – | 7.03% | 5 |
|
|
2025
Q4 | $12.7M | Hold |
55,400
| – | – | 7.08% | 4 |
|
|
2025
Q3 | $12.8M | Hold |
55,400
| – | – | 6.9% | 4 |
|
|
2025
Q2 | $10.3M | Buy |
55,400
+1,000
| +2% | +$186K | 5.8% | 6 |
|
|
2025
Q1 | $11.4M | Hold |
54,400
| – | – | 6.73% | 5 |
|
|
2024
Q4 | $9.67M | Sell |
54,400
-2,400
| -4% | -$441K | 5.8% | 6 |
|
|
2024
Q3 | $11.2M | Hold |
56,800
| – | – | 6.97% | 4 |
|
|
2024
Q2 | $9.74M | Sell |
56,800
-3,000
| -5% | -$497K | 6.4% | 5 |
|
|
2024
Q1 | $10.9M | Hold |
59,800
| – | – | 6.92% | 4 |
|
|
2023
Q4 | $9.27M | Sell |
59,800
-1,000
| -2% | -$146K | 6.55% | 4 |
|
|
2023
Q3 | $9.06M | Sell |
60,800
-450
| -0.7% | -$66.1K | 6.91% | 5 |
|
|
2023
Q2 | $8.25M | Hold |
61,250
| – | – | 5.64% | 5 |
|
|
2023
Q1 | $9.76M | Hold |
61,250
| – | – | 6.8% | 5 |
|
|
2022
Q4 | $9.9M | Hold |
61,250
| – | – | 7.04% | 5 |
|
|
2022
Q3 | $8.22M | Hold |
61,250
| – | – | 6.47% | 5 |
|
|
2022
Q2 | $9.38M | Hold |
61,250
| – | – | 6.88% | 4 |
|
|
2022
Q1 | $9.93M | Hold |
61,250
| – | – | 6.29% | 5 |
|
|
2021
Q4 | $8.29M | Hold |
61,250
| – | – | 4.97% | 6 |
|
|
2021
Q3 | $6.61M | Sell |
61,250
-400
| -0.6% | -$45.7K | 4.33% | 9 |
|
|
2021
Q2 | $6.94M | Hold |
61,650
| – | – | 4.39% | 9 |
|
|
2021
Q1 | $6.67M | Hold |
61,650
| – | – | 4.55% | 9 |
|
|
2020
Q4 | $6.61M | Buy |
61,650
+500
| +0.8% | +$48K | 4.8% | 6 |
|
|
2020
Q3 | $5.36M | Hold |
61,150
| – | – | 4.58% | 6 |
|
|
2020
Q2 | $6M | Hold |
61,150
| – | – | 5.34% | 5 |
|
|
2020
Q1 | $4.66M | Hold |
61,150
| – | – | 4.62% | 5 |
|
|
2019
Q4 | $5.41M | Sell |
61,150
-600
| -1% | -$49.8K | 4.19% | 8 |
|
|
2019
Q3 | $4.68M | Buy |
61,750
+10,400
| +20% | +$713K | 3.71% | 10 |
|
|
2019
Q2 | $3.73M | Sell |
51,350
-1,500
| -3% | -$118K | 3.04% | 11 |
|
|
2019
Q1 | $4.26M | Hold |
52,850
| – | – | 3.43% | 9 |
|
|
2018
Q4 | $4.87M | Hold |
52,850
| – | – | 4.51% | 6 |
|
|
2018
Q3 | $5M | Hold |
52,850
| – | – | 4.05% | 7 |
|
|
2018
Q2 | $4.9M | Buy |
52,850
+700
| +1% | +$68.4K | 4.31% | 7 |
|
|
2018
Q1 | $4.94M | Hold |
52,150
| – | – | 4.62% | 5 |
|
|
2017
Q4 | $5.04M | Hold |
52,150
| – | – | 4.6% | 6 |
|
|
2017
Q3 | $4.63M | Sell |
52,150
-2,100
| -4% | -$160K | 4.47% | 7 |
|
|
2017
Q2 | $3.93M | Hold |
54,250
| – | – | 3.54% | 10 |
|
|
2017
Q1 | $3.54M | Hold |
54,250
| – | – | 3.28% | 11 |
|
|
2016
Q4 | $3.4M | Buy |
54,250
+900
| +2% | +$54.9K | 3.21% | 12 |
|
|
2016
Q3 | $3.37M | Hold |
53,350
| – | – | 3.28% | 11 |
|
|
2016
Q2 | $3.3M | Hold |
53,350
| – | – | 3.4% | 10 |
|
|
2016
Q1 | $3.05M | Hold |
53,350
| – | – | 3.19% | 11 |
|
|
2015
Q4 | $3.16M | Sell |
53,350
-1,600
| -3% | -$92.2K | 3.43% | 11 |
|
|
2015
Q3 | $2.99M | Buy |
54,950
+1,400
| +3% | +$91.1K | 3.15% | 13 |
|
|
2015
Q2 | $3.6M | Sell |
53,550
-1,400
| -3% | -$91.4K | 3.51% | 10 |
|
|
2015
Q1 | $3.22M | Buy |
54,950
+23,850
| +77% | +$1.44M | 2.93% | 13 |
|
|
2014
Q4 | $2.04M | Hold |
31,100
| – | – | 1.86% | 22 |
|
|
2014
Q3 | $1.8M | Hold |
31,100
| – | – | 1.64% | 24 |
|
|
2014
Q2 | $1.75M | Buy |
31,100
+3,700
| +14% | +$194K | 1.64% | 25 |
|
|
2014
Q1 | $1.41M | Sell |
27,400
-3,700
| -12% | -$187K | 1.39% | 27 |
|
|
2013
Q4 | $1.64M | Buy |
+31,100
| New | +$1.53M | 1.62% | 22 |
|
Other funds holding ABBV
R.M. Sincerbeaux Capital Management's ABBV Position: Q2 2026 in Review
R.M. Sincerbeaux Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 55,400 shares worth $13.9M. The position accounts for 7.41% of the portfolio, ranked #4.
R.M. Sincerbeaux Capital Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- R.M. Sincerbeaux Capital Management held 55,400 shares of AbbVie worth $13.9M as of Q2 2026.
- R.M. Sincerbeaux Capital Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 7.41% of R.M. Sincerbeaux Capital Management's portfolio in Q2 2026, its #4 holding.
- R.M. Sincerbeaux Capital Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on R.M. Sincerbeaux Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.